LIM and SH3 Protein 1 (LASP1) (Middle Region) Peptid
LASP1
Reaktivität: Human
Wirt: Synthetic
BP, WB
-
- Target Alle LASP1 Produkte
- LASP1 (LIM and SH3 Protein 1 (LASP1))
- Protein Region
- Middle Region
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB)
- Sequenz
- ELQRIKKTQD QISNIKYHEE FEKSRMGPSG GEGMEPERRD SQDGSSYRRP
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-LASP1 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- LASP1 (LIM and SH3 Protein 1 (LASP1))
- Hintergrund
-
This gene encodes a member of a subfamily of LIM proteins, characterized by a LIM motif and a domain of Src homology region 3, and also a member of the nebulin family of actin-binding proteins. The encoded protein is a cAMP and cGMP dependent signaling protein and binds to the actin cytoskeleton at extensions of the cell membrane. The encoded protein has been linked to metastatic breast cancer, hematopoetic tumors such as B-cell lymphomas, and colorectal cancer.
Alias Symbols: MLN50, Lasp-1
Protein Size: 323 - Gen-ID
- 3927
- NCBI Accession
- NM_001271608, NP_001258537
-
Sie sind hier:
